The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 01, 2021

Filed:

Oct. 23, 2018
Applicant:

New Jersey Institute of Technology, Newark, NJ (US);

Inventors:

Eon Soo Lee, Tenafly, NJ (US);

Bharath Babu Nunna, Randolph, NJ (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01L 3/00 (2006.01); G01N 27/22 (2006.01); G01N 33/487 (2006.01); G01N 33/53 (2006.01); G01N 33/574 (2006.01); C01B 32/158 (2017.01); B82Y 30/00 (2011.01); B82Y 15/00 (2011.01);
U.S. Cl.
CPC ...
B01L 3/502715 (2013.01); B01L 3/50273 (2013.01); B01L 3/502761 (2013.01); G01N 27/226 (2013.01); G01N 33/48707 (2013.01); G01N 33/5304 (2013.01); G01N 33/57488 (2013.01); B01L 3/502746 (2013.01); B01L 2200/027 (2013.01); B01L 2300/023 (2013.01); B01L 2300/0645 (2013.01); B01L 2300/0819 (2013.01); B01L 2300/0883 (2013.01); B01L 2300/0896 (2013.01); B01L 2300/12 (2013.01); B01L 2300/161 (2013.01); B01L 2400/0406 (2013.01); B01L 2400/08 (2013.01); B01L 2400/088 (2013.01); B82Y 15/00 (2013.01); B82Y 30/00 (2013.01); C01B 32/158 (2017.08); G01N 2800/7028 (2013.01);
Abstract

A microfluidic biochip for detecting disease antigens using gold nano interdigitated electrode circuit under a controlled self-driven flow condition is disclosed. The biochip incorporates hydrophilic microchannels for controlled self-driven flow and gold nano interdigitated electrodes for capacitive sensing with enhanced sensitivity. The biochip's microchannel has a surface treated with oxygen plasma to control microchannel surface hydrophilicity and flow rate of the biofluid sample. Carbon Nanotubes (CNTs) are utilized as an intermediate layer to enhance the binding capability to nano electrodes to enhance sensitivity. Due to the carboxylic groups of the CNTs, covalent bond binding between the antibodies and the CNTs allows the antibodies to adhere more readily on the surface of the electrodes. The quantity of antibodies attaching to the surface is increased due to the high surface to area ratio in CNTs.


Find Patent Forward Citations

Loading…